Logo
b

biosurfit

61 employees

biosurfit is a european diagnostics and biotechnology company focused on the development, manufacture, and distribution of IVD tests for the point-of-care market with highly innovative proprietary technology and dedicated to provide comprehensive contract development and manufacturing services. biosurfit developed the spinit® technology, the first and only, diagnostics system capable of performing the major PoC blood test modalities (haematology, immunoassays and clinical chemistry) on the same instrument. The spinit® platform, integrates multiple diagnostic tests into a single device, delivering rapid and accurate results for healthcare professionals. Committed to improving patient outcomes, we combine cutting-edge research with practical applications to offer reliable, efficient, and user-friendly point-of-care diagnostic solutions. We want health providers to have all the necessary information to make the best possible diagnostic and treatment decision when they are with their patients. We are specialized in providing contract development and manufacturing services, leveraging our extensive portfolio of patents and expertise in microfluidics. Our commitment to innovation and excellence makes biosurfit a trusted partner for companies seeking advanced, turnkey manufacturing solutions in the healthcare industry.

Investor insights

Funding rounds participated in

$11M sweet spot round size

Investor type

Privately Held

Basic info

Industry

Biotechnology Research

Sectors

Biotechnology Research

Date founded

2006

Funding rounds raised

Total raised

$11M

from 1 investors over 1 rounds

b

biosurfit raised $11M on January 14, 2019

Investors: Boule Diagnostics

FAQ